Results of Bringing Rapid Amplicon based Sequencing to Doylestown Hospital

Wednesday, July 31
Time:11:00 - 11:20 a.m.
Location: Exhibit Hall Theater #2
Sponsored by Thermo Fisher Scientific

Overview

Recent years have seen advances in automation that have brought Next-Generation Sequencing (NGS) out of specialized reference laboratories and into local pathology departments. This innovation has allowed biomarker assessment to take place “in-house”, facilitating shorter turnaround times and more efficient use of laboratory resources. During this workshop, hear how one lab with no previous NGS experience was able to adopt a rapid, amplicon based NGS profiling assay via an automated semi-conductor sequencing system. You will hear about how utilizing automated amplicon-based sequencing in-house has resulted in reduced TAT and cost savings for Doylestown Hospital.

Speakers

Jesse Fox, Sr. Manager
North America Regional Market Development, Thermo Fisher Scientific

Allison Eck
Director of Pathology and Laboratory Medicine, Doylestown Hospital

You can Still Save on ADLM 2024

Take advantage of advanced rates by July 26 to save BIG. Members save even more! Learn more and register today!

Explore the conference program

ADLM 2024 offers something for everyone in laboratory medicine, from Plenaries featuring world-renowned scientists to intimate Roundtables.

Advertisement
Advertisement